| AMPICILLIN FOR INJECTION, USP (2 G) | 02226995 | Marketed | Fresenius Kabi Canada Ltd | Aug 2019 |
| AMPICILLIN FOR INJECTION, USP (1 G) | 02227002 | Marketed | Fresenius Kabi Canada Ltd | Aug 2019 |
| AMPICILLIN FOR INJECTION, USP (500 MG) | 02227010 | Marketed | Fresenius Kabi Canada Ltd | Aug 2019 |
| AMPICILLIN FOR INJECTION, USP (250 MG) | 02227029 | Marketed | Fresenius Kabi Canada Ltd | Aug 2019 |
| AMPICILLIN SODIUM FOR INJECTION BP (250 MG) | 02462303 | Marketed | Auro Pharma Inc. | Oct 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP (500 MG) | 02462311 | Marketed | Auro Pharma Inc. | Oct 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP (1 G) | 02462338 | Marketed | Auro Pharma Inc. | Oct 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP (2 G) | 02462346 | Marketed | Auro Pharma Inc. | Oct 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP (500 MG) | 02530481 | Marketed | Eugia Pharma Inc. | Aug 2024 |
| AMPICILLIN SODIUM FOR INJECTION BP (1 G) | 02530503 | Marketed | Eugia Pharma Inc. | Aug 2024 |
| AMPICILLIN SODIUM FOR INJECTION BP (2 G) | 02530511 | Marketed | Eugia Pharma Inc. | Aug 2024 |
| AMPICILLIN SODIUM FOR INJECTION, USP (250 MG) | 00872644 | Marketed | Teva Canada Limited | May 2014 |
| AMPICILLIN SODIUM FOR INJECTION, USP (500 MG) | 00872652 | Marketed | Teva Canada Limited | May 2014 |
| AMPICILLIN SODIUM FOR INJECTION, USP (1 G) | 01933345 | Marketed | Teva Canada Limited | May 2014 |
| AMPICILLIN SODIUM FOR INJECTION, USP (2 G) | 01933353 | Marketed | Teva Canada Limited | May 2014 |
| POLYFLEX (25 G) | 00849405 | Marketed | Boehringer Ingelheim Animal Health Canada Inc. | Jun 2021 |
| TEVA-AMPICILLIN (500 MG) | 00020885 | Marketed | Teva Canada Limited | Jul 2015 |
| TEVA-AMPICILLIN (250 MG) | 00020877 | Marketed | Teva Canada Limited | Jul 2015 |
| AMPICILLIN FOR INJECTION, USP (250 MG) | 02441705 | Approved | Sterimax Inc. | Jun 2015 |
| AMPICILLIN FOR INJECTION, USP (500 MG) | 02441713 | Approved | Sterimax Inc. | Jun 2015 |
| AMPICILLIN FOR INJECTION, USP (1 G) | 02441721 | Approved | Sterimax Inc. | Jun 2015 |
| AMPICILLIN FOR INJECTION, USP (2 G) | 02441748 | Approved | Sterimax Inc. | Jun 2015 |
| AMPICILLIN FOR INJECTION, USP (10 G) | 02441756 | Approved | Sterimax Inc. | Jun 2015 |
| AMPICILLIN SODIUM FOR INJECTION BP (250 MG) | 02530473 | Approved | Eugia Pharma Inc. | Sep 2022 |
| AMPICILLIN FOR INJECTION (125 MG) | 02227037 | Cancelled Pre Market | Fresenius Kabi Canada Ltd | Jul 2021 |
| AMPICILLIN SODIUM FOR INJECTION, BP (250 MG) | 02445093 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2022 |
| AMPICILLIN SODIUM FOR INJECTION, BP (500 MG) | 02445107 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2022 |
| AMPICILLIN SODIUM FOR INJECTION, BP (1000 MG) | 02445115 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2022 |
| AMPICILLIN SODIUM FOR INJECTION, BP (2000 MG) | 02445123 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2022 |
| AMPICIN FOR INJECTION 250MG (250 MG) | 00004049 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb | Jul 2002 |
| AMPICIN INJ 125MG/VIAL (125 MG) | 00605719 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb | Jul 2002 |
| AMPICIN INJ 1GM (1 G) | 00004065 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb | Jul 2002 |
| AMPICIN INJ 2000MG (2 G) | 00004073 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb | Jul 2002 |
| AMPICIN INJ 500MG (500 MG) | 00004057 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb | Jul 2002 |
| APO AMPI CAPSULES 250MG (250 MG) | 00603279 | Cancelled Post Market | Apotex Inc. | Dec 2019 |
| APO AMPI CAPSULES 500MG (500 MG) | 00603295 | Cancelled Post Market | Apotex Inc. | Dec 2019 |
| APO AMPI LIQ 125MG/5ML (125 MG) | 00603260 | Cancelled Post Market | Apotex Inc. | Apr 2019 |
| APO AMPI LIQ 250MG/5ML (250 MG) | 00603287 | Cancelled Post Market | Apotex Inc. | Apr 2019 |
| JAA AMP TAB 125MG (125 MG) | 00785873 | Cancelled Post Market | Jaapharm Canada Inc. | Aug 2010 |
| NOVO-AMPICILLIN PWS 500MG/5ML (500 MG) | 00231207 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NOVO-AMPICILLIN SUS 125MG/5ML (125 MG) | 00021121 | Cancelled Post Market | Novopharm Limited | Aug 2005 |
| NOVO-AMPICILLIN SUS 250MG/5ML (250 MG) | 00021148 | Cancelled Post Market | Novopharm Limited | Aug 2005 |
| NU-AMPI CAPSULES 250MG (250 MG) | 00717657 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMPI CAPSULES 500MG (500 MG) | 00717673 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMPI SUS 125MG/5ML (125 MG) | 00717495 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMPI SUSPENSION 250MG/5ML (250 MG) | 00717649 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| PENBRITIN CAP 250MG (250 MG) | 00002003 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN CAP 500MG (500 MG) | 00002011 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN INJ 1000MG (1 G) | 00002127 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN INJ 2000MG (2 G) | 00002135 | Cancelled Post Market | Ayerst Laboratories | Apr 1999 |
| PENBRITIN INJ 250MG (250 MG) | 00002100 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN INJ 500MG (500 MG) | 00002119 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN PWS 250MG/5ML (250 MG) | 00002429 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PENBRITIN-1000 PWS 1000MG/VIAL (1 G) | 02043173 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Apr 1999 |
| POLYFLEX (10 G) | 00857629 | Cancelled Post Market | Boehringer Ingelheim (Canada) Ltd. | Jul 2016 |
| PRO AMPI 250 CAP 250MG (250 MG) | 00251690 | Cancelled Post Market | Pro Doc Limitee | Jul 2003 |
| PRO AMPI 500 CAP 500MG (500 MG) | 00628360 | Cancelled Post Market | Pro Doc Limitee | Jul 2003 |
| PRO BIOSAN KIT (500 MG) | 00284009 | Cancelled Post Market | Icn Canada Ltd. | Aug 1998 |
| STERILE AMPICILLIN SODIUM 250MG USP (250 MG) | 02068540 | Cancelled Post Market | Bioniche Pharma (Canada) Ltd | Nov 2014 |
| SYNERGISTIN INJECTABLE SUSPENSION (120 MG) | 00698083 | Cancelled Post Market | Pfizer Canada Inc., Animal Health Group | Jul 2005 |
| TARO-AMPICILLIN CAP 250MG (250 MG) | 02030527 | Cancelled Post Market | Taro Pharmaceuticals Inc | Aug 2000 |
| TARO-AMPICILLIN CAP 500MG (500 MG) | 02030535 | Cancelled Post Market | Taro Pharmaceuticals Inc | Aug 2000 |